{{Rsnum
|rsid=3747676
|Gene=FGF2
|Chromosome=4
|position=122896919
|Orientation=plus
|GMAF=0.4178
|Gene_s=FGF2,NUDT6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 23.9 | 51.3 | 24.8
| HCB | 22.0 | 56.8 | 21.2
| JPT | 23.1 | 43.5 | 33.3
| YRI | 0.0 | 2.0 | 98.0
| ASW | 0.0 | 29.8 | 70.2
| CHB | 22.0 | 56.8 | 21.2
| CHD | 28.4 | 45.9 | 25.7
| GIH | 7.0 | 38.0 | 55.0
| LWK | 0.0 | 9.1 | 90.9
| MEX | 31.6 | 49.1 | 19.3
| MKK | 0.0 | 16.8 | 83.2
| TSI | 23.7 | 51.5 | 24.7
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19586755
|Title=Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
}}

{{PMID Auto
|PMID=18454203
|Title=Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}